Skip to main content
EnglishEnglish
EnglishEnglishArabicArabicChinese (Simplified)Chinese (Simplified)FrenchFrenchGermanGermanHindiHindiPortuguesePortugueseRussianRussianSpanishSpanishSwahiliSwahili

Header

  • Contact us
Home The Task Force for Global Health logo
  • https://twitter.com/GlobalHep
  • https://www.facebook.com/GlobalHep/
  • https://vimeo.com/globalhep
Donate
Add a Program
Add a Program
Profile
Logout

Main navigation

  • About
    • Who we are
    • What we do
    • Our team
    • Technical Advisory Board
    • Executive Board
    • Donor Acknowledgements
  • Programs
    • Programs search
  • Data dashboards
  • Evidence base
    • All evidence (search)
      • Evidence Base Methodology
    • Action plans
    • Hepatitis B Birth Dose Vaccine
      • Synthesis Brief of Hepatitis B Birth Dose Evidence Base
    • HCV Testing
    • COVID-19
      • Clinical Liver Disease COVID-19 special series
        • The COVID-19 Pandemic: An Epidemiologic, Public Health, and Clinical Brief
        • Synthesis of Liver Associations Recommendations for Hepatology and Liver Transplant Care During the COVID-19 Pandemic
      • COVID-19 and Liver Disease Synthesis
    • Innovations in Hepatitis Elimination (CLD Series)
      • Author Interviews
      • Introduction to Series
      • Past Publications
      • Author Guidance
  • Resources
    • Hepatitis Elimination Help Desk
    • Search resources
  • Webinars
    • Hep Test
    • Strategic Information Collaborative
    • HepB Birth Dose Introduction in AFRO
    • Innovations in Hepatitis Elimination
    • NIH Research Advancing Hepatitis Elimination
  • Elimination champions
    • Elimination Champions
    • Nominations for Elimination Champions
  • News
    • News search
  1. Home
  2. Evidence base
  3. Evidence base search

Evidence base articles search

The evidence base was developed using rigorous review methods for the identification and quality assessment of eligible systematic reviews and guideline and policy documents. In response to identified global research priorities, the evidence base currently presents characteristics of interventions to inform implementation of hepatitis B birth dose and hepatitis B and C action plans. Updates to the evidence base are planned to address subsequent priorities.

Edit

Evidence base search

Filter

  • (-) HCV testing
  • Hepatitis B
  • Hepatitis C
  • HBV testing and linkage to care
  • HCV testing and linkage to Care
  • Linkage to care
  • Persons who inject drugs: Medication assisted therapy
  • Screening and diagnosis
  • Testing
  • Treatment
  • Adolescents (10 - 19 years of age)
  • Adults
  • All ages
  • Birth cohorts of adults
  • Blood transfusion recipients
  • Dialysis patients
  • General Population
  • Immigrants/Refugees
  • Incarcerated populations (current and former)
  • Individuals with blood disorders
  • Men who have sex with men
  • Persons who inject drugs
  • Persons with substance use disorder
  • Pregnant women
  • Young Adults <21
  • Cross-sectional
  • Prospective cohort
  • Retrospective cohort
  • Australia
  • Belgium
  • Canada
  • China
  • Egypt
  • France
  • Germany
  • India
  • Iran (Islamic Republic of)
  • Ireland
  • Italy
  • Japan
  • Korea (Republic of)
  • Malaysia
  • Netherlands
  • Norway
  • Pakistan
  • Poland
  • Portugal
  • Serbia
  • Spain
  • Sri Lanka
  • Sweden
  • Taiwan
  • United Arab Emirates
  • United Kingdom
  • United States of America
  • Viet Nam
  • Laboratory-based antibody test
  • Laboratory-based antibody test,Laboratory-based HCV core antigen (cAg) confirmatory test
  • (-) Laboratory-based antibody test,Laboratory-based PCR/RNA (confirmatory) test
  • Laboratory-based antibody test, Point-of-care PCR/RNA test
  • Laboratory-based HCV core antigen (cAg) confirmatory test
  • Laboratory-based PCR/RNA (confirmatory) test
  • Point-of-care antibody test (rapid test)
  • Point-of-care antibody test (rapid test), Laboratory-based PCR/RNA (confirmatory) test
  • Point-of-care antibody test (rapid test), Point-of-care PCR/RNA test
  • Point-of-care antibody test (rapid test), Laboratory-based HCV core antigen (cAg) confirmatory test
  • Point-of-care PCR/RNA test
Displaying 1 - 12 of 101
  • Continuum of hepatitis C care in France: A 20-year cohort study

    2017
    PLoS ONE

    12

    e0183232
  • Preference, acceptability and implications of the rapid hepatitis C screening test among high-risk young people who inject drugs

    2014
    BMC Public Health

    14

    645
  • Laboratory screening for children entering foster care

    2017
    Pediatrics

    140

  • Opt-out screening for HIV, hepatitis B and hepatitis C: Observational study of screening acceptance, yield and treatment outcomes

    2019
    Emergency Medicine Journal.

    37

    102-105
  • A Regional Analysis of Hepatitis C Virus Collaborative Care With Pharmacists in Indian Health Service Facilities

    2018
    Journal of primary care & community health

    9

    1-5
  • High hepatitis C infection rate among baby boomers in an urban primary care clinic: Results from the HepTLC initiative

    2016
    Public Health Reports

    131

    49-56
  • Unrecognized chronic hepatitis C virus infection among baby boomers in the emergency department

    2015
    Hepatology

    61

    776-782
  • Prevalence of HCV Infection in Adults with Congenital Heart Disease and Treatment with Direct Antiviral Agents

    2018
    Southern Medical Journal

    111

    137-141
  • Elimination of hepatitis C virus infection in patients with haemophilia in Belgium: A single-centre experience

    2019
    Haemophilia

    25

    1028-1034
  • Characterizing failure to establish hepatitis C care of baby boomers diagnosed in the emergency department

    2016
    Open Forum Infectious Diseases

    3

    ofw211
  • Perinatal Transmission of Hepatitis C Virus: Defining the Cascade of Care

    2018
    Journal of Pediatrics

    203

    34-40
  • Treatment of hepatitis C infection among Egyptian hemodialysis patients: the dream becomes a reality

    2019
    International Urology and Nephrology

    51

    1639-1647

Pagination

  • Current page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • Next page ››
  • Last page Last »

Contact us

globalhep [at] taskforce.org

Tel: +1-404-371-0466

 

Photos on home page by Tayvessa Wilson, Conor Ashleigh, and Zunaid Murshed Paiker

Support us

Donate

Follow us

  • https://twitter.com/GlobalHep
  • https://www.facebook.com/GlobalHep/
  • https://vimeo.com/globalhep

Sign up to our newsletter

<

Footer

  • Contact
© 2019 - 2021 Coalition for Global Hepatitis Elimination
Website by Manta Ray Media
q